EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors

Creative Commons License

Kothmaier H., Quehenberger F., Halbwedl I., Morbini P., Demirag F., Zeren H., ...Daha Fazla

THORAX, cilt.63, sa.4, ss.345-351, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 63 Sayı: 4
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1136/thx.2007.085241
  • Dergi Adı: THORAX
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.345-351
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Background: Malignant pleural mesothelioma (MPM) is an asbestos related tumour difficult to detect early and treat effectively. Asbestos causes genetic modifications and cell signalling events that favour the resistance of MPM to apoptosis and chemotherapy. Only a small number of patients, approximately 10%, survive more than 3 years. The aim of our study was to assess possible differences within signalling pathways between short term survivors (survival <3 years; STS) and long term survivors (survival >3 years; LTS) of MPM.